Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
Qilu Pharma’s QL1706 Shows Promise in Phase II Cervical Cancer Study
January 31, 2025
Company
Deals
Organon Sponsors Retail Pharmacy Health Center at CIIE
January 31, 2025
Company
Deals
Sanofi Partners with China Resources Sanjiu at CIIE for Consumer Healthcare
January 31, 2025
Company
Deals
Sumitomo Dainippon Partners with Profex to Promote Antipsychotics in China
January 31, 2025
Company
Deals
Eli Lilly Partners with AmoyDx and Burning Rock for Retevmo Companion Diagnostics
February 1, 2025
Company
BioNTech’s Comirnaty Gets Limited Authorization in China Amid Scholz Visit
February 1, 2025
Company
Organon’s Q3 Results Show Women’s Health Segment Outperforms Amid Global Revenue Decline
February 1, 2025
Company
Deals
Organon Signs MOU with China’s National Health Commission at CIIE
February 1, 2025
Company
Drug
Ascletis Pharma Presents Phase I Study Results for ASC43F at AASLD
February 1, 2025
Company
Drug
Ji Xing Pharmaceuticals’ Omecamtiv Mecarbil Accepted for Review by CDE
February 1, 2025
Company
Deals
Sophway Raises ‘Tens of Millions’ in Angel Round for Endoscope Development
February 1, 2025
Company
Deals
CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment
February 1, 2025
1
2
…
1,100
1,101
1,102
1,103
1,104
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?